Hear from the Thalassaemia International Federation on what is new in Clinical Trials for Thalassaemia and Sickle Cell Disease

The Thalassaemia International Federation (TIF) released their Clinical Trials Update, a project which aims to provide an overview for patients and healthcare professionals on all clinical studies focusing on hemoglobin disorders thalassaemia and sickle cell disease. Please find the overview here.

Stay up to date

    © CSL 2026

    Blood & Beyond is a multi-stakeholder initiative funded by CSL, involving experts from the fields of haematology, transfusion medicine, anaesthesiology, patient blood management, nursing, patient advocacy, health economics, and hospital management, with support from policymakers committed to driving improvements in this area. The aim of the initiative is to raise awareness of the importance of good blood health and of the impact of anaemia on patients, healthcare systems and society at large, with the overarching goal to help advance policies and practices that improve patient outcomes by supporting patient-centricity in anaemia prevention, diagnosis, and management through patient blood management (PBM) and innovation.

    Contact

    For further information and queries, please contact the Blood and Beyond Secretariat: javier.lopezpanos@dgagroup.com

    Privacy Preference Center